The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART). (Q44218355)
Jump to navigation
Jump to search
scientific article published on 25 March 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART). |
scientific article published on 25 March 2009 |
Statements
1 reference
The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART). (English)
1 reference
K Schindler
1 reference
A Rieger
1 reference
A Tura
1 reference
B Gmeinhardt
1 reference
V Touzeau-Römer
1 reference
D Haider
1 reference
G Pacini
1 reference
B Ludvik
1 reference
25 March 2009
1 reference
1 reference
Identifiers
1 reference